You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY20 is not expected to be complete until September, 2021.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Eco: An Online Virtual World for Middle School Environmental Literacy and Collaborative Problem Solving

    SBC: STRANGE LOOP GAMES INC.            Topic: EDIES15R0008

    Video Demonstration of the Phase I Prototype: https://www.youtube.com/watch?v=PsvXXII2zzw&index=5&list=PLVHqsnePfULrUf_-HwtRfwEYsb9patGd- Purpose: This project will develop and test Eco, an online multiplayer virtual environment and game designed to enhance middle school students' knowledge of ecology and environmental literacy. This is important because according to the 2011 National Assessment ...

    SBIR Phase II 2015 Department of EducationInstitute of Education Sciences
  2. IGF OT IGF SBIR PHASE II TOPIC TITLE A VASCULARIZED TUMOR MICROENVIRONMENT ASSAY FOR THE SCREENING OF ANTI CANCER DRUGS

    SBC: Nortis, Inc.            Topic: NCI

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  3. IGF OT IGF INHALED DRUG COMBINATION FOR TUBERCULOSIS THERAPY

    SBC: PAI Life Sciences, Inc.            Topic: NIAID

    Not Available

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  4. A DOPPLER SIMULATOR FOR VASCULAR ULTRASOUND TRAINING

    SBC: Sheehan Medical LLC            Topic: NIBIB

    DESCRIPTION provided by applicant Doppler ultrasound is relied upon as the primary and often the only test used to diagnose vascular pathology Because variations in technical skill directly impact surgical referral decisions there is a strong clinical need to ensure that provides both attain and maintain skills in this procedure The problem we address is the lack of a quantitative or standar ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  5. In vivo validation of Universal Donor Cells

    SBC: UNIVERSAL CELLS INC.            Topic: 200

    DESCRIPTION provided by applicant Pluripotent stem cells have the potential to treat diseases affecting almost every organ system However their clinical use is limited by host rejection due to differences in the diverse Major Histocompatibility Complex MHC genes In the past this problem has been addressed by using MHC matched donors and or dangerous immunosuppressive drug regimens Here ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  6. Stroke Treatment by Chemically-induced Hypothermia

    SBC: JT Pharmaceuticals, Inc.            Topic: 101

    DESCRIPTION provided by applicant Stroke is a leading cause of human death and disability in the United States while clinical therapy for acute stroke is limited and unsatisfactoy The many failures in clinical trials strongly endorse the idea that to battle this multifaceted bran disorder novel strategies that target multiple cell types and different mechanisms are needed to achieve therapeut ...

    STTR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  7. Radioactive Stents for Brachytherapy of Esophageal Cancers

    SBC: XL Sci Tech Inc            Topic: 102

    DESCRIPTION provided by applicant Current practice in the USA for inoperable esophageal cancer is a palliative treatment using metal stent for end stage cancer patients Outside the USA especially in far east countries including China and Korea there have been reported clinical benefits of attaching sealed sources such as prostate seeds to the outside of an esophageal stent Although sim ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  8. Optimization and Validation of an Indicator Cell Assay for Blood-Based Diagnosis of Alzheimers Disease

    SBC: PreCyte Inc            Topic: NIA

    DESCRIPTION provided by applicant We are developing the Indicator Cell Assay Platform iCAP a broadly applicable and inexpensive platform for blood based diagnostics that can be used for early detection of disease and as a companion diagnostic for drug development The iCAP uses cultured cells as biosensors capitalizing on the ability of cells to respond differently to signals present in th ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  9. An integrated genotyping approach for HLA and other genetic systems

    SBC: SCISCO GENETICS INC            Topic: NIAID

    DESCRIPTION provided by applicant Next Generation Sequencing NGS technologies provide a key mechanism in the expansion of precision medicine wherein treatments are designed based on the genetics unique to an individual patientandapos s illness A long standing and effective application of this concept has been in the clinical arena of hematopoietic cell transplants HCTs where for over ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
  10. Clinical Evaluation of a Novel Prostate Cancer PET Diagnostic

    SBC: CANCER TARGETED TECHNOLOGY LLC            Topic: 102

    DESCRIPTION provided by applicant Prostate cancer PCa is the most commonly diagnosed cancer and second leading cause of cancer death in American men The utility of the widely accepted diagnostic test for PCa the PSA test has come under severe scrutiny as only of men with PCa have levels that fall within the current PSA reference range Elevated PSA levels are not correlated well wit ...

    SBIR Phase II 2015 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government